BREAST CANCER INVESTMENT CYCLE STATUS

(Updated 3-12-24)

Overview of Our Investment Process

CANCER FUND invests in cycles focused on cancer or innovation type through the community-driven, six step investment process shown below.

82 Companies

Internal review all pipeline companies identifed for the cycle

16 Companies

Cycle advisor review of select innovations from Step 1

4 Companies

Screening Committee QUICK-LOOK reviews of select innovators from Step 2

2 Companies

CLOSER-LOOK town hall discussion / Q&A with from Step 3

2 Companies

DEEP DIVE evaluation of investment opportunity for companies from Step 4

TBD Companies

Final investment execution

Cycle Status

The status of individual companies under consideration in our Breast Cancer Investment Cycle are shown below.

Oral therapeutic inhibiting mitochondria functions for cancer treatment without side effects

Veana Therapeutics has progressed to Step 5 – Due Diligence.

The company has garnered $17,050 in soft investment committments to date, 68% of our target investment total of $25,000. Click Here for more information.

 

Molecular Breast Imaging platform for cancer detection in women with dense breasts where standard mammography lacks detection sensitivity

SmartBreast has progressed to Step 5 – Due Diligence.

The company has garnered $13,450 in soft investment committments to date, 54% of our target investment total of $25,000. Click Here for more information..

AI-powered ultrasound breast cancer detection platform designed for clinical use by any healthcare professional

ISono Health has been favorably received and generated soft investment commitments but not yet sufficient interest to progress to Step 5 – Due Diligence. The company remains at Step 4 until sufficient investment interest is generated. 

A smart drug delivery platform that can carry existing, approved chemotherapy treatment directly to cancer tumor cells, reducing treatment side effects

Peptinovo has been favorably received and generated soft investment commitments but not yet sufficient interest to progress to Step 5 – Due Diligence. The company remains at Step 4 until sufficient investment interest is generated.